Novo Nordisk

Novo Nordisk acquisition of Biocorp. A big deal in the Smartpen world?

06/06/2023 admin 1

Novo Nordisk’s acquisition of Biocorp demonstrates how insulin manufacturers are looking to take the next step in optimising insulin delivery, opening up better access to AI techniques for MDI users.

Insulin Icodec – the once a week long acting insulin from Novo Nordisk

18/06/2020 admin 13

If you’ve been following the ADA Scientific Sessions, you’ll have seen lots of big device announcements and AID information, but you may have missed this […]

Fiasp and the ONSET5 Trial – What Novo Nordisk found in the CSII (pump) Clinical trial

Fiasp and the Onset 5 CSII Trial – What Novo Nordisk found

14/08/2018 admin 6

Around the time of launching Fiasp, Novo Nordisk embarked on a wider study of its use in Continuous Subcutaneous Insulin Infusion (CSII), or pumping as […]